Header Logo

Connection

ISHA KAUL to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications ISHA KAUL has written about Xenograft Model Antitumor Assays.
ISHA KAUL
Connection Strength
0.019
Xenograft Model Antitumor Assays
  1. Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma. Oncotarget. 2017 Mar 28; 8(13):21741-21753.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.